CORMEDIX INC. Tax Withholding Paid on Stock Awards
CORMEDIX INC. (CRMD) reported Tax Withholding Paid on Stock Awards of $1.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-13
- CORMEDIX INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $131.00K, a 46.96% decline year-over-year.
- CORMEDIX INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $1.53M, a 49.85% increase year-over-year.
- CORMEDIX INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $257.44K, a 382.23% increase year-over-year.
- CORMEDIX INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $464.56K.
- CORMEDIX INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.99M, a 585.52% increase from fiscal 2024.
- CORMEDIX INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $290.00K, a 46.14% increase from fiscal 2023.
- CORMEDIX INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $198.44K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 3 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $131.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.66M 10-Q · filed 2026-08-13 | $1.92M derived: sum of 3 quarters · filed 2026-08-13 | $2.38M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $1.53M 10-Q · filed 2026-05-14 | $1.78M derived: sum of 2 quarters · filed 2026-05-14 | $2.25M derived: sum of 3 quarters · filed 2026-05-14 | $2.50M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $257.44K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $722.00K derived: sum of 2 quarters · filed 2026-03-05 | $969.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.99M 10-K · filed 2026-03-05 | |||
| 2025-09-30 | $464.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $711.56K derived: sum of 2 quarters · filed 2026-08-13 | $1.73M 10-Q · filed 2025-11-12 | $1.78M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $247.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.27M 10-Q · filed 2026-08-13 | $1.27M 10-Q · filed 2025-08-07 | $1.32M derived: sum of 3 quarters · filed 2026-08-13 | $1.32M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $1.02M 10-Q · filed 2026-05-14 | $1.02M 10-Q · filed 2025-05-06 | $1.07M derived: sum of 2 quarters · filed 2026-05-14 | $1.07M derived: sum of 3 quarters · filed 2026-05-14 | $1.21M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $53.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $53.38K derived: sum of 2 quarters · filed 2026-03-05 | $192.88K derived: sum of 3 quarters · filed 2026-03-05 | $290.00K 10-K · filed 2026-03-05 | $289.62K 10-K · filed 2025-03-25 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $139.50K derived: sum of 2 quarters · filed 2025-11-12 | $236.62K 10-Q · filed 2025-11-12 | $236.62K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $139.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $236.62K 10-Q · filed 2025-08-07 | $236.62K derived: sum of 3 quarters · filed 2025-08-07 | $236.62K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $97.12K 10-Q · filed 2025-05-06 | $97.12K derived: sum of 2 quarters · filed 2025-05-06 | $97.12K derived: sum of 3 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $1.00 derived: sum of 2 quarters · filed 2025-03-25 | $198.44K 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $198.44K 10-Q · filed 2024-10-30 | |||||
| 2023-06-30 | $198.44K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |